Member Info for Bothwell

Is the delay’s in the US & China due to Dr Mike Wylie no longer being involved?

They have arrived.

News | Pacific Medical Systems Limited - Deltex's TrueVue™ Oesophageal Doppler Monitoring System - official Asia Launch during the 18th World Congress of Anaesthesiologists 2024

Very happy to be working so closely with Pacific Medical Systems in Asia and looking forward to seeing the business really develop across the region under their management.

Having a great week at Kimes 2024 in Seoul, showcasing the new TrueVue monitor with the Department for Business and Trade. Exhibiting alongside other really innovative UK companies, it's been a hectic week so far, but really interesting, with great feedback.

South Korea is a great place for UK companies to establish their products, within a healthcare system that has the ability to implement new technologies.

A big thanks to the Department for Business and Trade in Seoul for all their help in arranging this. They have done a really great job.

World Congress of Anaesthesia

Great first morning at the WCA in Singapore. Lots of interest in the launch of the new TrueVue monitor and amazing support provided by our Asia partner company Pacific Medical Systems Limited

Is today the day our luck changes…

Date of Board Meeting

The board of directors (the “Board”) of Regent Pacific Group Limited

(the “Company”) announces that a meeting of the Board will be held on

Wednesday, 27 March 2024 for the purpose of, among other matters, approving

the final results of the Company and its subsidiaries for the year ended

31 December 2023 and its publication, and considering the recommendation on

the payment of a final dividend, if any.

I was told soon…

When do we expect our next operational update as it must be soon. What are we hoping for?

Just seen this.

I would say it is going to pick up again soon or a takeover will happen.

ABHI US Accelerator

We are so proud to be partnering with the brilliant team at Deltex Medical, who are leading the way in haemodynamic monitoring. Their innovative Esophageal Doppler Monitoring technology is making waves in #surgery and #criticalcare, providing real-time insights for anaesthetists.

Operational update coming soon…..

Hopefully positive news!

They didn’t know…

We have a product that is required my many men around the world and we have approval for many countries at this moment in time and I know we still have the US and China to come. Why has there never been a marketing campaign?

It would appear that Fortacin was approved in Singapore on the 5th July 2022, was this covered before?

Yes and this was released on 17 April 2023…….

Can’t be long until we get an update….

Jamie Gibson, CEO of the Group, said, “We are delighted with the highly significant and positive

results from the Phase 3 clinical study in China, which reinforces the results from the European

and US Phase 3 clinical studies. This represents an important milestone in the regulatory

submission process in China. We now look forward to our commercial partner in China submitting the New Drug Application (“NDA”) to National Medical Products Administration (“NMPA”) by the

end of Q3 2023 with approval expected 12 months later.”

Jamie Gibson further added, “Senstend has the potential to help about 9 million patients in

China during its first year of launch, growing to over 170 million by the tenth year. Our strong

partner Wanbang Biopharmaceutical, who benefits from being part of the Fosun network. This

company has the marketing expertise established e-commerce platforms and an unrivalled

nationwide logic and distribution through Sinopharm, China’s number one pharmaceutical and healthcare distributor, through its network of hospitals, clinics and pharmacies to ensure the

commercial success of Senstend in China.

Sent email to Jamie and Dr Mike a number of weeks ago and no response. They would always respond before.

Https://markets.ft.com/data/equities/tearsheet/forecasts?s=DEMG:LSE

Https://www.risingmaster.com/fortacin/

Https://www.auajournals.org/doi/epdf/10.1097/JU.0000000000003291.05

Https://delta.larvol.com/products/?ProductId=a4fee3a3-4bd3-43c8-909c-0d3f221df3cc&ProductName=Fortacin%20(lidocaine/prilocaine%20spray)&Institutions=+Regent+Pacific+Group%2C+Recordati&Index=0